Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PATIENT EDUCATION patienteducation.osumc.edu Graft Versus Host Disease (GVHD) Graft Versus Host Disease or GVHD is a problem that can occur after allogeneic and matched unrelated bone marrow transplants (BMT). About 40-50% of patients may have this problem. It occurs more frequently in matched unrelated or mismatched transplants. This handout gives general information about GVHD. What causes GVHD? GVHD is a response of the immune system. It is caused by the immune cells or “lymphocytes” of the new bone marrow. These lymphocytes see body cells of the recipient as being different. These lymphocytes may attack and destroy specific body cells. This results in graft versus host disease. Graft versus host means: Graft - Donor bone marrow and immune cells or lymphocytes given to the recipient Versus - Against Host - Recipients body cells Types of GVHD There are two different types of GVHD. Review the chart of GVHD symptoms on the next page. Acute GVHD Acute GVHD may develop within 3 months after transplant. It may begin to occur when blood counts recover after transplant. It usually affects the skin, gastrointestinal (GI) tract and liver. The symptoms of acute GVHD happen quickly and can be mild or severe. This handout is for informational purposes only. Talk with your doctor or health care team if you have any questions about your care. © May 22, 2014. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Chronic Chronic GVHD may occur from three months to a year or longer after transplant. Chronic GVHD symptoms progress slowly and can be mild or severe. Usually chronic symptoms are mild and can be controlled by medicines. Prevention/Treatment Special medicines are given to prevent acute and chronic GVHD. These medicines are started before your transplant. The medicines are used to slow down or suppress the immune system, to prevent GVHD. These medicines can also be used to treat GVHD by adjusting the dosages. Examples of medicines are cyclosporine, tacrolimus (Prograf7), mycophenolate (Cellcept7), methotrexate, and steroids. Your doctor or nurse will give you more information about these medicines. GVHD Skin • Redness of palms of Acute hands and soles of feet • Rash over parts of the body • Sensitive, itching or dry skin • Darkened and dry Chronic skin • Peeling of skin GI Tract • Diarrhea • Nausea • Loss of appetite • Abdominal cramps Liver Lungs Eyes • Enlarged liver • Increased liver functions tests* (bloodwork) • Abdominal tenderness • Diarrhea • Weight loss • Difficulty eating or loss of appetite • Dry mouth • A gradual increase in liver functions tests* (bloodwork) • Dry eyes • Hard to take deep • Sensitivity breaths to light • Shortness of breath • Enlarged liver • Abdominal tenderness • Yellowish color of skin and eyes *Liver function tests - Bloodwork that allows us to see how the liver is working. Graft vs. Host Disease (GVHD)